Additional file 6: Figure S3 Assessment of the prognostic risk signature. A K-M survival analysis in Subgrp7-CD1 between the high- and low-risk groups in training set and TCGA. B-F K-M survival analysis in OS, iss1, gender, del17pcyto, and del16qclinicalfish between the two risk groups in GSE13633
Background. An increasing number of studies have indicated that the abnormal expression of certain l...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
Additional file 5: Figure S2 Assessment of the prognostic risk signature in GSE136337. A The distrib...
Additional file 4: Figure S1 Assessment of the prognostic risk signature in TCGA. A The distribution...
Additional file 2: Table S2 Differential IC50s observed for 168 drugs in two group
Abstract Background About 10% of hematologic malignancies are multiple myeloma (MM), an untreatable ...
Additional file 7: Figure S4 Effects of Nelarabine, Carmustine and Temozolomide on apoptotic death, ...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
List of enriched GO terms and KEGG pathways of mRNAs co-expressed with prognostic lncRNAs. (XLS 72Â ...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Background. An increasing number of studies have indicated that the abnormal expression of certain l...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
Additional file 5: Figure S2 Assessment of the prognostic risk signature in GSE136337. A The distrib...
Additional file 4: Figure S1 Assessment of the prognostic risk signature in TCGA. A The distribution...
Additional file 2: Table S2 Differential IC50s observed for 168 drugs in two group
Abstract Background About 10% of hematologic malignancies are multiple myeloma (MM), an untreatable ...
Additional file 7: Figure S4 Effects of Nelarabine, Carmustine and Temozolomide on apoptotic death, ...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
List of enriched GO terms and KEGG pathways of mRNAs co-expressed with prognostic lncRNAs. (XLS 72Â ...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Background: Multiple myeloma (MM) is one of the most common types of hematological malignance, and t...
Background. An increasing number of studies have indicated that the abnormal expression of certain l...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...